Redcare Pharmacy NV (WBO:SHOP) Cyclically Adjusted PS Ratio: (As of Jul. 30, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

WBO:SHOP Redcare Pharmacy NV WBO:SHOP
65 GF Score
Price €68.85
GF Value €178.65
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Redcare Pharmacy NV Cyclically Adjusted PS Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Redcare Pharmacy NV  (WBO:SHOP) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Redcare Pharmacy NV Cyclically Adjusted PS Ratio Related Terms


Redcare Pharmacy NV Cyclically Adjusted PS Ratio Historical Data

* Premium members only.

The historical data trend for Redcare Pharmacy NV's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Redcare Pharmacy NV Cyclically Adjusted PS Ratio Chart

Redcare Pharmacy NV Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 2.00 0.84

Redcare Pharmacy NV Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.32 0.98 0.84 0.46 0.00

Redcare Pharmacy NV Cyclically Adjusted PS Ratio Competitor Comparison

For the Pharmaceutical Retailers subindustry, Redcare Pharmacy NV's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Redcare Pharmacy NV Cyclically Adjusted PS Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Redcare Pharmacy NV's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Redcare Pharmacy NV's Cyclically Adjusted PS Ratio falls into.


WBO:SHOP
65GF Score
Redcare Pharmacy NV WBO:SHOP
Cyclically Adjusted PS Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Redcare Pharmacy NV Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Redcare Pharmacy NV's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, Redcare Pharmacy NV's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=42.296/138.6000*138.6000
=42.296

Current CPI (Jun. 2026) = 138.6000.

Redcare Pharmacy NV Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 4.689 100.570 6.462
201612 5.811 100.710 7.997
201703 7.032 101.440 9.608
201706 6.938 101.370 9.486
201709 7.107 102.030 9.654
201712 7.723 101.970 10.497
201803 10.871 102.470 14.704
201806 10.529 103.100 14.154
201809 10.870 103.950 14.493
201812 12.524 103.970 16.695
201903 14.463 105.370 19.024
201906 12.889 105.840 16.878
201909 12.691 106.700 16.485
201912 14.250 106.800 18.493
202003 17.230 106.850 22.350
202006 16.641 107.510 21.453
202009 13.308 107.880 17.098
202012 14.760 107.850 18.968
202103 15.834 108.870 20.158
202106 13.837 109.670 17.487
202109 13.145 110.790 16.445
202112 15.917 114.010 19.350
202203 16.843 119.460 19.542
202206 15.788 119.050 18.381
202209 15.634 126.890 17.077
202212 18.014 124.940 19.984
202303 20.444 124.720 22.719
202306 22.444 125.830 24.722
202309 23.912 127.160 26.063
202312 26.720 126.450 29.287
202403 27.977 128.580 30.157
202406 28.000 129.910 29.873
202409 28.577 131.610 30.095
202412 33.582 131.630 35.360
202503 35.678 133.330 37.088
202506 35.264 133.960 36.485
202509 35.760 135.920 36.465
202512 39.538 135.270 40.511
202603 42.238 136.910 42.759
202606 42.296 138.600 42.296

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Redcare Pharmacy NV (WBO:SHOP) Overvalued in 2026?

Based on GuruFocus' analysis, Redcare Pharmacy NV stock appears to be undervalued. The current stock price of €68.85 is trading 61.5% below its estimated GF Value™ of €178.65. GuruFocus considers Redcare Pharmacy NV to be Significantly Undervalued.

Key valuation signals for WBO:SHOP:

  • Cyclically Adjusted PS Ratio:
  • GF Value™: €178.65 vs. price of €68.85 (61.5% below fair value)
  • GF Score™: 65/100 with 2 warning signs

No single metric tells the full story. See the WBO:SHOP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Redcare Pharmacy NV Business Description

Address Erik de Rodeweg 11/13, Sevenum, ZH, NLD, 5975 WD
Redcare Pharmacy NV is an online pharmacy business for prescription and nonprescription (over-the-counter) pharmaceuticals, beauty and personal care products (BPC) and food supplements. Besides OTC, nutritional supplements, beauty and personal care products as well as an extensive assortment of health-related products in all markets, the company also provides prescription drugs for customers in Germany, Switzerland and the Netherlands. It operates in two segments, namely DACH segment that includes sales in Germany, Austria and Switzerland; and the International segment that includes sales across Belgium, the Netherlands, France and Italy. The DACH segment accounts for the majority of the revenue.
65GF Score

Get the complete analysis for WBO:SHOP

Cyclically Adjusted PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€68.85
Price
€178.65
GF Value